Resistance to BRAF Drugs In Melanoma may be Overcome by Blocking Autophagy With Malaria Drug

Melanoma patients with BRAF mutation usually have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression. Now, a new preclinical study published online ahead of print in the ia/i from Penn Medicine researchers found that in many cases the root of the resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and ...

Read More
You have just read an article categorized health titled Resistance to BRAF Drugs In Melanoma may be Overcome by Blocking Autophagy With Malaria Drug.
Written by: editor - Tuesday, February 25, 2014

There are currently no comments for "Resistance to BRAF Drugs In Melanoma may be Overcome by Blocking Autophagy With Malaria Drug"

Post a Comment